Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

449 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Frequent sugar feeding behavior by Aedes aegypti in Bamako, Mali makes them ideal candidates for control with attractive toxic sugar baits (ATSB).
Sissoko F, Junnila A, Traore MM, Traore SF, Doumbia S, Dembele SM, Schlein Y, Traore AS, Gergely P, Xue RD, Arheart KL, Revay EE, Kravchenko VD, Beier JC, Müller GC. Sissoko F, et al. Among authors: gergely p. PLoS One. 2019 Jun 17;14(6):e0214170. doi: 10.1371/journal.pone.0214170. eCollection 2019. PLoS One. 2019. PMID: 31206547 Free PMC article.
Large-scale field trial of attractive toxic sugar baits (ATSB) for the control of malaria vector mosquitoes in Mali, West Africa.
Traore MM, Junnila A, Traore SF, Doumbia S, Revay EE, Kravchenko VD, Schlein Y, Arheart KL, Gergely P, Xue RD, Hausmann A, Beck R, Prozorov A, Diarra RA, Kone AS, Majambere S, Bradley J, Vontas J, Beier JC, Müller GC. Traore MM, et al. Among authors: gergely p. Malar J. 2020 Feb 14;19(1):72. doi: 10.1186/s12936-020-3132-0. Malar J. 2020. PMID: 32059671 Free PMC article.
Testing configurations of attractive toxic sugar bait (ATSB) stations in Mali, West Africa, for improving the control of malaria parasite transmission by vector mosquitoes and minimizing their effect on non-target insects.
Diarra RA, Traore MM, Junnila A, Traore SF, Doumbia S, Revay EE, Kravchenko VD, Schlein Y, Arheart KL, Gergely P, Hausmann A, Beck R, Xue RD, Prozorov AM, Kone AS, Majambere S, Vontas J, Beier JC, Müller GC. Diarra RA, et al. Among authors: gergely p. Malar J. 2021 Apr 14;20(1):184. doi: 10.1186/s12936-021-03704-3. Malar J. 2021. PMID: 33853632 Free PMC article.
The Pyraloidea (Lepidoptera) fauna of the woody savannah belt in Mali, West Africa.
Poltavsky AN, Kravchenko VD, Traore MM, Traore SF, Gergely P, Witt TJ, Sulak H, Beck RH, Junnila A, Revay EE, Doumbia S, Beier JC, Muller GC. Poltavsky AN, et al. Among authors: gergely p. Zootaxa. 2018 Aug 7;4457(1):39-69. doi: 10.11646/zootaxa.4457.1.2. Zootaxa. 2018. PMID: 30314179 Free PMC article.
Case Report: A Sudden Thyroid-Related Death of a 15-Year-Old Girl.
Rácz K, Simon G, Kurucz A, Harsányi GT, Török M, Herczeg LT, Gergely PA. Rácz K, et al. Among authors: gergely pa. Diagnostics (Basel). 2024 Apr 26;14(9):905. doi: 10.3390/diagnostics14090905. Diagnostics (Basel). 2024. PMID: 38732319 Free PMC article.
Lethal threat in the use of glass doors at home: A case report.
Halasi BD, Borsay BÁ, Pórszász RK, Gergely PA. Halasi BD, et al. Among authors: gergely pa. Leg Med (Tokyo). 2024 Feb;66:102365. doi: 10.1016/j.legalmed.2023.102365. Epub 2023 Nov 24. Leg Med (Tokyo). 2024. PMID: 38041907
Efficacy and safety of iscalimab, a novel anti-CD40 monoclonal antibody, in moderate-to-severe myasthenia gravis: A phase 2 randomized study.
GomezMancilla B, Meriggioli MN, Genge A, Roubenoff R, Espié P, Dupuy C, Hartmann N, Pezous N, Kinhikar A, Tichy M, Dionne A, Vissing J, Andersen H, Schoser B, Meisel A, Jordan B, Devlikamova F, Poverennova I, Stuchevskaya F, Lin TS, Rush JS, Gergely P. GomezMancilla B, et al. Among authors: gergely p. J Clin Neurosci. 2024 Jan;119:76-84. doi: 10.1016/j.jocn.2023.11.013. Epub 2023 Nov 20. J Clin Neurosci. 2024. PMID: 37988976 Clinical Trial.
Efficacy and safety of remibrutinib, a selective potent oral BTK inhibitor, in Sjögren's syndrome: results from a randomised, double-blind, placebo-controlled phase 2 trial.
Dörner T, Kaul M, Szántó A, Tseng JC, Papas AS, Pylvaenaeinen I, Hanser M, Abdallah N, Grioni A, Santos Da Costa A, Ferrero E, Gergely P, Hillenbrand R, Avrameas A, Cenni B, Siegel RM. Dörner T, et al. Among authors: gergely p. Ann Rheum Dis. 2024 Feb 15;83(3):360-371. doi: 10.1136/ard-2023-224691. Ann Rheum Dis. 2024. PMID: 37932009 Free PMC article. Clinical Trial.
449 results